Page last updated: 2024-08-21

aminoimidazole carboxamide and Centriacinar Emphysema

aminoimidazole carboxamide has been researched along with Centriacinar Emphysema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, XY; Huang, C; Li, J; Li, YY; Yao, HW	1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Centriacinar Emphysema

Article	Year
AMP-activated protein kinase reduces inflammatory responses and cellular senescence in pulmonary emphysema. Oncotarget, 2017, Apr-04, Volume: 8, Issue:14 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line; Cellular Senescence; Energy Metabolism; Female; Humans; Inflammation; Lipid Metabolism; Lung; Male; Mice; Mice, Inbred C57BL; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrazoles; Pyrimidines; Respiratory Mucosa; Ribonucleotides; Smoking	2017

Article

Year

AMP-activated protein kinase reduces inflammatory responses and cellular senescence in pulmonary emphysema.

Oncotarget, 2017, Apr-04, Volume: 8, Issue:14

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line; Cellular Senescence; Energy Metabolism; Female; Humans; Inflammation; Lipid Metabolism; Lung; Male; Mice; Mice, Inbred C57BL; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrazoles; Pyrimidines; Respiratory Mucosa; Ribonucleotides; Smoking

2017